ORIGINAL ARTICLE

Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations

I S Patel¹, T A R Seemungal¹, M Wilks², S J Lloyd-Owen¹, G C Donaldson¹, J A Wedzicha¹

¹ Academic Respiratory Medicine, St Bartholomew's and Royal London School of Medicine and Dentistry, London EC1A 7BE, UK
² Microbiology and Virology Clinical Group, St Bartholomew's and the Royal London Hospital NHS Trust, London EC1A 7BE, UK

Correspondence to:
Correspondence to:
Professor J A Wedzicha, Academic Unit of Respiratory Medicine, Dominion House, St Bartholomew's Hospital, London EC1A 7BE, UK;
J.A.Wedzicha{at}qmul.ac.uk

Background: Patients with chronic obstructive pulmonary disease (COPD) are prone to frequent exacerbations which are a significant cause of morbidity and mortality. Stable COPD patients often have lower airway bacterial colonisation which may be an important stimulus to airway inflammation and thereby modulate exacerbation frequency.

Methods: Twenty nine patients with COPD (21 men, 16 current smokers) of mean (SD) age 65.9 (7.84) years, forced expiratory volume in 1 second (FEV₁) 1.06 (0.41) l, FEV₁ % predicted 38.7 (15.2)%, FEV₁/FVC 43.7 (14.1)%, inhaled steroid dosage 1.20 (0.66) mg/day completed daily diary cards for symptoms and peak flow over 18 months. Exacerbation frequency rates were determined from diary card data. Induced sputum was obtained from patients in the stable state, quantitative bacterial culture was performed, and cytokine levels were measured.

Results: Fifteen of the 29 patients (51.7%) were colonised by a possible pathogen: Haemophilus influenzae (53.3%), Streptococcus pneumoniae (33.3%), Haemophilus parainfluenzae (20%), Branhamella catarrhalis (20%), Pseudomonas aeruginosa (20%). The presence of lower airway bacterial colonisation in the stable state was related to exacerbation frequency (p=0.023). Patients colonised by H influenzae in the stable state reported more symptoms and increased sputum purulence at exacerbation than those not colonised. The median (IQR) symptom count at exacerbation in those colonised by H influenzae was 2.00 (2.00–2.65) compared with 2.00 (1.00–2.00) in those not colonised (p=0.03). The occurrence of increased sputum purulence at exacerbation per patient was 0.92 (0.56–1.00) in those colonised with H influenzae and 0.33 (0.00–0.60) in those not colonised (p=0.02). Sputum interleukin (IL)-8 levels correlated with the total bacterial count (rho=0.459, p=0.02).

Conclusion: Lower airway bacterial colonisation in the stable state modulates the character and frequency of COPD exacerbations.

Keywords: chronic obstructive pulmonary disease; exacerbation frequency; bacterial colonisation

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Miravitlles, M., Marin, A., Monso, E., Vila, S., de la Roza, C., Hervas, R., Esquinas, C., Garcia, M., Millares, L., Morera, J., Torres, A. (2009). Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD. Eur Respir J 34: 1066-1071 [Abstract] [Full Text]  
• Hallstrom, T., Blom, A. M., Zipfel, P. F., Riesbeck, K. (2009). Nontypeable Haemophilus influenzae Protein E Binds Vitronectin and Is Important for Serum Resistance. J. Immunol. 183: 2593-2601 [Abstract] [Full Text]  
• Brusselle, G. G., Demoor, T., Bracke, K. R., Brandsma, C-A., Timens, W. (2009). Lymphoid follicles in (very) severe COPD: beneficial or harmful?. Eur Respir J 34: 219-230 [Abstract] [Full Text]  
• Roede, B. M., Bresser, P., Prins, J. M., Schellevis, F., Verheij, T. J. M., Bindels, P. J. E. (2009). Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD. Eur Respir J 33: 282-288 [Abstract] [Full Text]  
• Korbila, I. P., Manta, K. G., Siempos, I. I., Dimopoulos, G., Falagas, M. E. (2009). Penicillins vs trimethoprim-based regimens for acute bacterial exacerbations of chronic bronchitis: Meta-analysis of randomized controlled trials. cfp 55: 60-67 [Abstract] [Full Text]  
• Braman, S. S. (2009). Chronic Obstructive Pulmonary Disease. ACCP Pulmonary Med Brd Rev 25: 153-186 [Full Text]  
• Seemungal, T. A. R., Wilkinson, T. M. A., Hurst, J. R., Perera, W. R., Sapsford, R. J., Wedzicha, J. A. (2008). Long-term Erythromycin Therapy Is Associated with Decreased Chronic Obstructive Pulmonary Disease Exacerbations. Am. J. Respir. Crit. Care Med. 178: 1139-1147 [Abstract] [Full Text]  
• Wedzicha, J. A (2008). Antibiotics at COPD exacerbations: the debate continues. Thorax 63: 940-942 [Full Text]  
• Pasqua, F., Biscione, G., Crigna, G., Cazzola, M. (2008). Prulifloxacin in the treatment of acute exacerbations of COPD in cigarette smokers. Ther Adv Respir Dis 2: 209-214 [Abstract]  
• Wilson, R. (2008). Short course of antibiotic treatment in acute exacerbations of COPD. Thorax 63: 390-392 [Full Text]  
• Murphy, T. F., Brauer, A. L., Eschberger, K., Lobbins, P., Grove, L., Cai, X., Sethi, S. (2008). Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 177: 853-860 [Abstract] [Full Text]  
• Slevogt, H., Maqami, L., Vardarowa, K., Beermann, W., Hocke, A. C., Eitel, J., Schmeck, B., Weimann, A., Opitz, B., Hippenstiel, S., Suttorp, N., N'Guessan, P. D. (2008). Differential regulation of Moraxella catarrhalis-induced interleukin-8 response by protein kinase C isoforms. Eur Respir J 31: 725-735 [Abstract] [Full Text]  
• Groenewegen, K. H., Postma, D. S., Hop, W. C. J., Wielders, P. L. M. L., Schlosser, N. J. J., Wouters, E. F. M., for the COSMIC Study Group, (2008). Increased Systemic Inflammation Is a Risk Factor for COPD Exacerbations*. Chest 133: 350-357 [Abstract] [Full Text]  
• Miravitlles, M. (2007). Review: Do we need new antibiotics for treating exacerbations of COPD?. Ther Adv Respir Dis 1: 61-76 [Abstract]  
• Mukundan, D., Ecevit, Z., Patel, M., Marrs, C. F., Gilsdorf, J. R. (2007). Pharyngeal Colonization Dynamics of Haemophilus influenzae and Haemophilus haemolyticus in Healthy Adult Carriers. J. Clin. Microbiol. 45: 3207-3217 [Abstract] [Full Text]  
• Powrie, D. J., Wilkinson, T. M. A., Donaldson, G. C., Jones, P., Scrine, K., Viel, K., Kesten, S., Wedzicha, J. A. (2007). Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD. Eur Respir J 30: 472-478 [Abstract] [Full Text]  
• Ko, F. W. S., Ip, M., Chan, P. K. S., Chan, M. C. H., To, K.-W., Ng, S. S. S., Chau, S. S. L., Tang, J. W., Hui, D. S. C. (2007). Viral Etiology of Acute Exacerbations of COPD in Hong Kong. Chest 132: 900-908 [Abstract] [Full Text]  
• Wilkinson, T. M. A. (2007). Host Pathogen Interactions during COPD Exacerbations: Moving on from Microbiology by Numbers?. Am. J. Respir. Crit. Care Med. 176: 323-325 [Full Text]  
• Naylor, E. J., Bakstad, D., Biffen, M., Thong, B., Calverley, P., Scott, S., Hart, C. A., Moots, R. J., Edwards, S. W. (2007). Haemophilus influenzae Induces Neutrophil Necrosis: A Role in Chronic Obstructive Pulmonary Disease?. Am. J. Respir. Cell Mol. Bio. 37: 135-143 [Abstract] [Full Text]  
• Dimopoulos, G., Siempos, I. I., Korbila, I. P., Manta, K. G., Falagas, M. E. (2007). Comparison of First-Line With Second-Line Antibiotics for Acute Exacerbations of Chronic Bronchitis: A Metaanalysis of Randomized Controlled Trials. Chest 132: 447-455 [Abstract] [Full Text]  
• Celli, B. R., Barnes, P. J. (2007). Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 29: 1224-1238 [Abstract] [Full Text]  
• Cote, C. G., Dordelly, L. J., Celli, B. R. (2007). Impact of COPD Exacerbations on Patient-Centered Outcomes. Chest 131: 696-704 [Abstract] [Full Text]  
• Perera, W. R., Hurst, J. R., Wilkinson, T. M. A., Sapsford, R. J., Mullerova, H., Donaldson, G. C., Wedzicha, J. A. (2007). Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J 29: 527-534 [Abstract] [Full Text]  
• Yoshikawa, T., Dent, G., Ward, J., Angco, G., Nong, G., Nomura, N., Hirata, K., Djukanovic, R. (2007). Impaired Neutrophil Chemotaxis in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 175: 473-479 [Abstract] [Full Text]  
• Ko, F. W.S., Ip, M., Chan, P. K.S., Fok, J. P.C., Chan, M. C.H., Ngai, J. C., Chan, D. P.S., Hui, D. S.C. (2007). A 1-Year Prospective Study of the Infectious Etiology in Patients Hospitalized With Acute Exacerbations of COPD. Chest 131: 44-52 [Abstract] [Full Text]  
• Soler, N., Agusti, C., Angrill, J., Puig De la Bellacasa, J., Torres, A. (2007). Bronchoscopic validation of the significance of sputum purulence in severe exacerbations of chronic obstructive pulmonary disease. Thorax 62: 29-35 [Abstract] [Full Text]  
• Roghanian, A., Drost, E. M., MacNee, W., Howie, S. E. M., Sallenave, J.-M. (2006). Inflammatory Lung Secretions Inhibit Dendritic Cell Maturation and Function via Neutrophil Elastase. Am. J. Respir. Crit. Care Med. 174: 1189-1198 [Abstract] [Full Text]  
• Davies, G., Wells, A. U., Doffman, S., Watanabe, S., Wilson, R. (2006). The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis. Eur Respir J 28: 974-979 [Abstract] [Full Text]  
• Takabatake, N., Shibata, Y., Abe, S., Wada, T., Machiya, J.-i., Igarashi, A., Tokairin, Y., Ji, G., Sato, H., Sata, M., Takeishi, Y., Emi, M., Muramatsu, M., Kubota, I. (2006). A Single Nucleotide Polymorphism in the CCL1 Gene Predicts Acute Exacerbations in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 174: 875-885 [Abstract] [Full Text]  
• Berenson, C. S., Wrona, C. T., Grove, L. J., Maloney, J., Garlipp, M. A., Wallace, P. K., Stewart, C. C., Sethi, S. (2006). Impaired Alveolar Macrophage Response to Haemophilus Antigens in Chronic Obstructive Lung Disease. Am. J. Respir. Crit. Care Med. 174: 31-40 [Abstract] [Full Text]  
• Schussler, O., Alifano, M., Dermine, H., Strano, S., Casetta, A., Sepulveda, S., Chafik, A., Coignard, S., Rabbat, A., Regnard, J.-F. (2006). Postoperative Pneumonia after Major Lung Resection. Am. J. Respir. Crit. Care Med. 173: 1161-1169 [Abstract] [Full Text]  
• Wedzicha, J. A., Wilkinson, T. (2006). Impact of Chronic Obstructive Pulmonary Disease Exacerbations on Patients and Payers. Proc Am Thorac Soc 3: 218-221 [Abstract] [Full Text]  
• Scott, S, Walker, P, Calverley, P M A (2006). COPD exacerbations {middle dot} 4: Prevention. Thorax 61: 440-447 [Abstract] [Full Text]  
• O'Donnell, R, Breen, D, Wilson, S, Djukanovic, R (2006). Inflammatory cells in the airways in COPD. Thorax 61: 448-454 [Abstract] [Full Text]  
• Roghanian, A., Williams, S. E., Sheldrake, T. A., Brown, T. I., Oberheim, K., Xing, Z., Howie, S. E. M., Sallenave, J.-M. (2006). The Antimicrobial/Elastase Inhibitor Elafin Regulates Lung Dendritic Cells and Adaptive Immunity. Am. J. Respir. Cell Mol. Bio. 34: 634-642 [Abstract] [Full Text]  
• Sethi, S., Maloney, J., Grove, L., Wrona, C., Berenson, C. S. (2006). Airway Inflammation and Bronchial Bacterial Colonization in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 173: 991-998 [Abstract] [Full Text]  
• Vlahos, R., Bozinovski, S., Jones, J. E., Powell, J., Gras, J., Lilja, A., Hansen, M. J., Gualano, R. C., Irving, L., Anderson, G. P. (2006). Differential protease, innate immunity, and NF-{kappa}B induction profiles during lung inflammation induced by subchronic cigarette smoke exposure in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L931-L945 [Abstract] [Full Text]  
• Wilkinson, T. M. A., Donaldson, G. C., Johnston, S. L., Openshaw, P. J. M., Wedzicha, J. A. (2006). Respiratory Syncytial Virus, Airway Inflammation, and FEV1 Decline in Patients with Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 173: 871-876 [Abstract] [Full Text]  
• van der Strate, B. W. A., Postma, D. S., Brandsma, C.-A., Melgert, B. N., Luinge, M. A., Geerlings, M., Hylkema, M. N., van den Berg, A., Timens, W., Kerstjens, H. A. M. (2006). Cigarette Smoke-induced Emphysema: A Role for the B Cell?. Am. J. Respir. Crit. Care Med. 173: 751-758 [Abstract] [Full Text]  
• Wilson, R, Jones, P, Schaberg, T, Arvis, P, Duprat-Lomon, I, Sagnier, P P, for the MOSAIC Study Group, (2006). Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis. Thorax 61: 337-342 [Abstract] [Full Text]  
• Sapey, E, Stockley, R A (2006). COPD exacerbations {middle dot} 2: Aetiology.. Thorax 61: 250-258 [Abstract] [Full Text]  
• Avadhanula, V., Rodriguez, C. A., Ulett, G. C., Bakaletz, L. O., Adderson, E. E. (2006). Nontypeable Haemophilus influenzae Adheres to Intercellular Adhesion Molecule 1 (ICAM-1) on Respiratory Epithelial Cells and Upregulates ICAM-1 Expression. Infect. Immun. 74: 830-838 [Abstract] [Full Text]  
• Sethi, S. (2006). Coinfection in Exacerbations of COPD: A New Frontier.. Chest 129: 223-224 [Full Text]  
• Wilkinson, T. M. A., Hurst, J. R., Perera, W. R., Wilks, M., Donaldson, G. C., Wedzicha, J. A. (2006). Effect of Interactions Between Lower Airway Bacterial and Rhinoviral Infection in Exacerbations of COPD.. Chest 129: 317-324 [Abstract] [Full Text]  
• Stevenson, N. J., Walker, P. P., Costello, R. W., Calverley, P. M. A. (2005). Lung Mechanics and Dyspnea during Exacerbations of Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 172: 1510-1516 [Abstract] [Full Text]  
• Soler-Cataluna, J J, Martinez-Garcia, M A, Roman Sanchez, P, Salcedo, E, Navarro, M, Ochando, R (2005). Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60: 925-931 [Abstract] [Full Text]  
• Donaldson, G. C., Seemungal, T. A. R., Patel, I. S., Bhowmik, A., Wilkinson, T. M. A., Hurst, J. R., MacCallum, P. K., Wedzicha, J. A. (2005). Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD. Chest 128: 1995-2004 [Abstract] [Full Text]  
• Wilson, R. (2005). Treatment of COPD exacerbations: antibiotics. ERR 14: 32-38 [Abstract] [Full Text]  
• Johnston, S. L. (2005). Overview of Virus-induced Airway Disease. Proc Am Thorac Soc 2: 150-156 [Abstract] [Full Text]  
• Barnes, P. J., Stockley, R. A. (2005). COPD: current therapeutic interventions and future approaches. Eur Respir J 25: 1084-1106 [Abstract] [Full Text]  
• Talbot, T. R., Hartert, T. V., Mitchel, E., Halasa, N. B., Arbogast, P. G., Poehling, K. A., Schaffner, W., Craig, A. S., Griffin, M. R. (2005). Asthma as a Risk Factor for Invasive Pneumococcal Disease. NEJM 352: 2082-2090 [Abstract] [Full Text]  
• Rosell, A., Monso, E., Soler, N., Torres, F., Angrill, J., Riise, G., Zalacain, R., Morera, J., Torres, A. (2005). Microbiologic Determinants of Exacerbation in Chronic Obstructive Pulmonary Disease. Arch Intern Med 165: 891-897 [Abstract] [Full Text]  
• Hurst, J. R., Wilkinson, T. M. A., Perera, W. R., Donaldson, G. C., Wedzicha, J. A. (2005). Relationships Among Bacteria, Upper Airway, Lower Airway, and Systemic Inflammation in COPD. Chest 127: 1219-1226 [Abstract] [Full Text]  
• Lee, D. K. C., Khoo, K. C., Dushianthan, A., Currie, G. P. (2005). Are Colonial Haemophilus influenzae Responsible for Exacerbations of Chronic Obstructive Pulmonary Disease After All?. Am. J. Respir. Crit. Care Med. 171: 194-194 [Full Text]  
• Miravitlles, M., Torres, A. (2004). Antibiotics in exacerbations of COPD: lessons from the past. Eur Respir J 24: 896-897 [Full Text]  
• Lode, H., Eller, J., Linnhoff, A., Ioanas, M., the Evaluation of Therapy-Free Interval in COPD Pa, (2004). Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval. Eur Respir J 24: 947-953 [Abstract] [Full Text]  
• Barnes, P. J. (2004). Mediators of Chronic Obstructive Pulmonary Disease. Pharmacol. Rev. 56: 515-548 [Abstract] [Full Text]  
• Hurst, J R, Wedzicha, J A (2004). Chronic obstructive pulmonary disease: the clinical management of an acute exacerbation. Postgrad. Med. J. 80: 497-505 [Abstract] [Full Text]  
• Patel, I. S., Vlahos, I., Wilkinson, T. M. A., Lloyd-Owen, S. J., Donaldson, G. C., Wilks, M., Reznek, R. H., Wedzicha, J. A. (2004). Bronchiectasis, Exacerbation Indices, and Inflammation in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 170: 400-407 [Abstract] [Full Text]  
• Vestbo, J (2004). Chronic bronchitis: should it worry us?. Chronic Respiratory Disease 1: 173-176 [Abstract]  
• Paggiaro, P. (2004). Does Early Treatment of Exacerbation Improve Outcome in Chronic Obstructive Pulmonary Disease?. Am. J. Respir. Crit. Care Med. 169: 1267-1268 [Full Text]  
• Wilkinson, T. M. A., Donaldson, G. C., Hurst, J. R., Seemungal, T. A. R., Wedzicha, J. A. (2004). Early Therapy Improves Outcomes of Exacerbations of Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 169: 1298-1303 [Abstract] [Full Text]  
• Wedzicha, J. A. (2004). Role of Viruses in Exacerbations of Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 1: 115-120 [Abstract] [Full Text]  
• Calverley, P. M. A. (2004). Reducing the Frequency and Severity of Exacerbations of Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 1: 121-124 [Abstract] [Full Text]  
• Miravitlles, M., Torres, A. (2004). No More Equivalence Trials for Antibiotics in Exacerbations of COPD, Please. Chest 125: 811-813 [Full Text]  
• Bogaert, D., van der Valk, P., Ramdin, R., Sluijter, M., Monninkhof, E., Hendrix, R., de Groot, R., Hermans, P. W. M. (2004). Host-Pathogen Interaction during Pneumococcal Infection in Patients with Chronic Obstructive Pulmonary Disease. Infect. Immun. 72: 818-823 [Abstract] [Full Text]  
• Kim, S., Emerman, C. L., Cydulka, R. K., Rowe, B. H., Clark, S., Camargo, C. A. (2004). Prospective Multicenter Study of Relapse Following Emergency Department Treatment of COPD Exacerbation. Chest 125: 473-481 [Abstract] [Full Text]  
• Message, S. D., Johnston, S. L. (2004). Host defense function of the airway epithelium in health and disease: clinical background. J. Leukoc. Biol. 75: 5-17 [Abstract] [Full Text]  
• Donaldson, G.C., Seemungal, T.A.R., Patel, I.S., Lloyd-Owen, S.J., Wilkinson, T.M.A., Wedzicha, J.A. (2003). Longitudinal changes in the nature, severity and frequency of COPD exacerbations. Eur Respir J 22: 931-936 [Abstract] [Full Text]  
• Oudijk, E{-}J.D., Lammers, J{-}W.J., Koenderman, L. (2003). Systemic inflammation in chronic obstructive pulmonary disease. Eur Respir J 22: 5s-13s [Abstract] [Full Text]  
• Barnes, P.J., Shapiro, S.D., Pauwels, R.A. (2003). Chronic obstructive pulmonary disease: molecular and cellularmechanisms. Eur Respir J 22: 672-688 [Abstract] [Full Text]  
• White, A J, Gompertz, S, Bayley, D L, Hill, S L, O'Brien, C, Unsal, I, Stockley, R A (2003). Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis. Thorax 58: 680-685 [Abstract] [Full Text]  
• Burge, S., Wedzicha, J.A. (2003). COPD exacerbations: definitions and classifications. Eur Respir J 21: 46S-53s [Abstract] [Full Text]  
• Partridge, M R (2003). Patients with COPD: do we fail them from beginning to end?. Thorax 58: 373-375 [Full Text]  
• Wilkinson, T. M. A., Patel, I. S., Wilks, M., Donaldson, G. C., Wedzicha, J. A. (2003). Airway Bacterial Load and FEV1 Decline in Patients with Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 167: 1090-1095 [Abstract] [Full Text]  
• King, P. T., Hutchinson, P. E., Johnson, P. D., Holmes, P. W., Freezer, N. J., Holdsworth, S. R. (2003). Adaptive Immunity to Nontypeable Haemophilus influenzae. Am. J. Respir. Crit. Care Med. 167: 587-592 [Abstract] [Full Text]  
• Donaldson, G C, Seemungal, T A R, Bhowmik, A, Wedzicha, J A (2002). Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57: 847-852 [Abstract] [Full Text]  
• Kidney, J, McManus, T, Coyle, P V (2002). Exacerbations of chronic obstructive pulmonary disease. Thorax 57: 753-754 [Full Text]